In hematological malignancies, OTX-015 has been shown to target, in addition to c-MYC, also the NFKB/TLR/JAK/STAT signaling and to synergize with everolimus in B-cells lymphoma in vitro and in vivo [189,190]. The gene discussed is MYC; the disease is hematologic disorder.